FY2025 · ended Dec 31, 2025 · Revenue $194.06M, +25.3% YoY · Filed Mar 10, 2026
LifeMD, Inc. (LFMD) files with the SEC under industry code 8011, Services-Offices & Clinics of Doctors of Medicine. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $194.1 million and net income of $14.4 million. Free cash flow was $6.4 million. As of Jun 30, 2026 it held $25.1 million in cash and investments and $6.0 million in total debt.
Revenue (TTM)
$191.59M
+19.8% vs year-ago TTM
Net income (TTM)
$201,011
+102.1% vs year-ago TTM
Operating cash flow (TTM)
$-9.91M
-150.9% vs year-ago TTM
Free cash flow (TTM)
$-11.06M
-161.6% vs year-ago TTM
EPS (TTM)
$-0.06
+79.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
47.97M
+7.6% vs prior year
Net cash
$19.12M
as of Jun 30, 2026
Operating margin
-10.5%
FY 2026
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- LFMD (Nasdaq), LFMDP (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Accelerated filer
- SEC CIK
- 948320
- Former names
- CONVERSION LABS, INC. (until Feb 22, 2021); Immudyne, Inc. (until Jun 19, 2018)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- Starling Oncology, Inc. STLN
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $194.1M | $154.8M | $152.5M | $119.0M | $92.9M |
| Operating income | -$7.7M | -$20.4M | -$14.5M | -$43.4M | -$54.3M |
| Net income | $14.4M | -$21.4M | -$20.6M | -$45.5M | -$60.9M |
| Diluted EPS | $0.25 | — | — | — | — |
| Operating cash flow | $8.3M | $17.5M | $8.8M | -$22.9M | -$33.1M |
| Free cash flow | $6.4M | $16.0M | $8.6M | -$23.3M | -$33.3M |
| Total assets | $70.4M | $76.1M | $58.5M | $25.7M | $49.9M |
| Total liabilities | $47.3M | $83.7M | $52.9M | $33.0M | $24.1M |
| Stockholders' equity | $23.2M | -$9.1M | $3.5M | -$11.4M | $22.7M |
| Cash and investments | $36.8M | — | — | $14.6M | — |
| Total debt | $6.3M | $6.8M | $677,029 | $1.3M | $1.8M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 15, 2026 | Sep 15, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 22, 2026 | Jun 22, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
All 578 LifeMD, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.